2017-11-08 22:12:06 UTC

Image Challenge: An Unusual Cause of Dysphagia in an Elderly Woman

Nov. 8, 2017

What caused a 66-year-old woman, with occurrence of hemoptysis several days before presenting, one month of dysphagia?

Gastroenterology Clinical Image Challenge:  A 66-year-old woman came to the hospital complaining of dysphagia for one month. She denied a family history of gastrointestinal carcinoma and a history of previous surgery. Remarkable previous history of bronchiectasis in the past years and occurrence of hemoptysis several days before was provided. The patient denied alcohol consumption and smoking habits. Upon presentation, no positive findings were found on the physical examination or laboratory studies. Esophagogastroduodenoscopy revealed a smooth, hemispherical, 8-mm diameter lesion on the posterior side of her esophagus at the level of carina (Figure). Using a Miniprobe sonography, an echoless vessel-like structure connected to the thoracic aorta was identified where the lesion was found. Doppler ultrasound imaging demonstrated rich blood flow signals inside the vessel-like structure. These signals originated from the thoracic aorta.

What is the diagnosis?

To find out the diagnosis, read the full case in Gastroenterology or download our Clinical Image Challenge app through AGA App Central, which features new cases each week. Sort and filter by organ, most popular or favorites. AGA App Central is available in both the Apple App Store and Google Play.

 

More on Dyspepsia / Non-Ulcer Dyspepsia

Save the Date: 2018 AGA Postgraduate Course

Jan. 11, 2018

This year’s course will take place on June 2 and 3, 2018, in Washington, D.C.

Digestive Disease Week® (DDW)

Dec. 19, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.

Innovation is Needed in Functional Dyspepsia Drug Development

Aug. 22, 2017

Functional dyspepsia is not a one-size-fits-all condition, which is a challenge for drug development. But promising new trials are underway.